Archive

Latest California Healthline Stories

Watch: Why Infusion Drugs Come With Sticker Shock

The story of an Ohio mom who faced an outrageous bill for a new medicine for multiple sclerosis is the latest installment in the “Bill of the Month” series, an ongoing crowdsourced investigation by KHN and NPR.

Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS

Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.

Playing On Fear And Fun, Hospitals Follow Pharma In Direct-To-Consumer Advertising

Hospitals are increasingly advertising medical services directly to patients to enhance their national brands. They think the image building improves their ability to negotiate with health plans and brings in wealthier patients.

Buyers Of Short-Term Health Plans: Wise Or Shortsighted?

Policyholders reason that their health is good — for now — and they don’t see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. “You basically have to be in perfect health,” says one.